这是一篇来自已证抗体库的有关人类 Notch1的综述,是根据137篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合Notch1 抗体。
Notch1 同义词: AOS5; AOVD1; TAN1; hN1

艾博抗(上海)贸易有限公司
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 5a
艾博抗(上海)贸易有限公司 Notch1抗体(Abcam, ab83232)被用于被用于免疫印迹在人类样本上 (图 5a). Cancer Cell Int (2019) ncbi
domestic rabbit 单克隆(EP1238Y)
  • 免疫印迹; 人类; 图 9b
艾博抗(上海)贸易有限公司 Notch1抗体(Abcam, ab52627)被用于被用于免疫印迹在人类样本上 (图 9b). Cancer Cell Int (2019) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:1000; 图 5e
艾博抗(上海)贸易有限公司 Notch1抗体(Abcam, ab8925)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 5e). Biosci Rep (2019) ncbi
domestic rabbit 多克隆
  • 免疫细胞化学; 斑马鱼; 图 s7c
艾博抗(上海)贸易有限公司 Notch1抗体(Abcam, ab8387)被用于被用于免疫细胞化学在斑马鱼样本上 (图 s7c). Cell (2019) ncbi
domestic rabbit 单克隆(EP1238Y)
  • 免疫印迹; 小鼠; 1:1000; 图 5o
艾博抗(上海)贸易有限公司 Notch1抗体(Abcam, ab52627)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 5o). Science (2018) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:75; 图 4b
艾博抗(上海)贸易有限公司 Notch1抗体(Abcam, ab27526)被用于被用于免疫印迹在人类样本上浓度为1:75 (图 4b). Biosci Rep (2018) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 1:500; 图 4o
艾博抗(上海)贸易有限公司 Notch1抗体(Abcam, ab8925)被用于被用于免疫印迹在小鼠样本上浓度为1:500 (图 4o). Genes Dev (2017) ncbi
domestic rabbit 多克隆
  • 其他; 小鼠; 图 6f
  • 免疫组化-石蜡切片; 小鼠; 图 5c
艾博抗(上海)贸易有限公司 Notch1抗体(Abcam, ab8925)被用于被用于其他在小鼠样本上 (图 6f) 和 被用于免疫组化-石蜡切片在小鼠样本上 (图 5c). J Biol Chem (2017) ncbi
domestic rabbit 多克隆
  • 免疫组化; 大鼠; 1:100; 图 5a
艾博抗(上海)贸易有限公司 Notch1抗体(Abcam, ab52301)被用于被用于免疫组化在大鼠样本上浓度为1:100 (图 5a). PLoS ONE (2017) ncbi
domestic rabbit 多克隆
  • 免疫细胞化学; 人类; 1:200; 图 7a
艾博抗(上海)贸易有限公司 Notch1抗体(Abcam, ab8925)被用于被用于免疫细胞化学在人类样本上浓度为1:200 (图 7a). Sci Rep (2017) ncbi
domestic rabbit 多克隆
  • 免疫细胞化学; 人类; 图 2a
  • 免疫印迹; 人类; 图 2c
艾博抗(上海)贸易有限公司 Notch1抗体(Abcam, ab8925)被用于被用于免疫细胞化学在人类样本上 (图 2a) 和 被用于免疫印迹在人类样本上 (图 2c). Clin Cancer Res (2017) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 1:1000; 图 7e
艾博抗(上海)贸易有限公司 Notch1抗体(Abcam, ab8925)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 7e). Nat Commun (2017) ncbi
domestic rabbit 单克隆(EP1238Y)
  • 免疫印迹; 小鼠; 1:200; 图 3c
艾博抗(上海)贸易有限公司 Notch1抗体(Abcam, EP1238Y)被用于被用于免疫印迹在小鼠样本上浓度为1:200 (图 3c). J Clin Invest (2017) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 大鼠; 图 4a
艾博抗(上海)贸易有限公司 Notch1抗体(Abcam, ab8925)被用于被用于免疫印迹在大鼠样本上 (图 4a). Am J Transl Res (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 1k
  • 免疫组化; 小鼠; 1:25; 图 s1c
  • 免疫印迹; 小鼠; 图 1a
艾博抗(上海)贸易有限公司 Notch1抗体(Abcam, ab52301)被用于被用于免疫印迹在人类样本上 (图 1k), 被用于免疫组化在小鼠样本上浓度为1:25 (图 s1c) 和 被用于免疫印迹在小鼠样本上 (图 1a). J Clin Invest (2017) ncbi
domestic rabbit 单克隆(EP1238Y)
  • 免疫细胞化学; 人类; 图 8a
  • 免疫组化-冰冻切片; 小鼠; 图 6b
艾博抗(上海)贸易有限公司 Notch1抗体(Abcam, ab52627)被用于被用于免疫细胞化学在人类样本上 (图 8a) 和 被用于免疫组化-冰冻切片在小鼠样本上 (图 6b). Cell Death Dis (2016) ncbi
domestic rabbit 单克隆(EP1238Y)
  • 免疫印迹; 人类; 图 s2
艾博抗(上海)贸易有限公司 Notch1抗体(Abcam, ab52627)被用于被用于免疫印迹在人类样本上 (图 s2). Proc Natl Acad Sci U S A (2016) ncbi
domestic rabbit 多克隆
  • 免疫组化; 大鼠; 1:1000; 图 5
艾博抗(上海)贸易有限公司 Notch1抗体(Abcam, ab8925)被用于被用于免疫组化在大鼠样本上浓度为1:1000 (图 5). Alzheimers Res Ther (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 图 1h
  • 免疫组化-石蜡切片; 人类; 1:1000; 图 4a
艾博抗(上海)贸易有限公司 Notch1抗体(Abcam, ab8925)被用于被用于免疫印迹在小鼠样本上 (图 1h) 和 被用于免疫组化-石蜡切片在人类样本上浓度为1:1000 (图 4a). J Exp Med (2016) ncbi
domestic rabbit 多克隆
  • 免疫组化; 小鼠; 1:200; 图 1
艾博抗(上海)贸易有限公司 Notch1抗体(Abcam, ab8925)被用于被用于免疫组化在小鼠样本上浓度为1:200 (图 1). Nat Commun (2016) ncbi
domestic rabbit 多克隆
  • 免疫细胞化学; 大鼠; 1:100; 图 1g
  • 免疫印迹; 大鼠; 1:500; 图 4c
艾博抗(上海)贸易有限公司 Notch1抗体(Abcam, ab8925)被用于被用于免疫细胞化学在大鼠样本上浓度为1:100 (图 1g) 和 被用于免疫印迹在大鼠样本上浓度为1:500 (图 4c). PLoS ONE (2016) ncbi
domestic rabbit 多克隆
  • 免疫细胞化学; 大鼠; 1:100; 图 1g
艾博抗(上海)贸易有限公司 Notch1抗体(Abcam, ab27526)被用于被用于免疫细胞化学在大鼠样本上浓度为1:100 (图 1g). PLoS ONE (2016) ncbi
domestic rabbit 多克隆
  • 免疫组化-石蜡切片; 人类; 图 6
  • 免疫印迹; 人类; 图 6
艾博抗(上海)贸易有限公司 Notch1抗体(Abcam, Ab83232)被用于被用于免疫组化-石蜡切片在人类样本上 (图 6) 和 被用于免疫印迹在人类样本上 (图 6). Sci Rep (2016) ncbi
domestic rabbit 单克隆(EP1238Y)
  • 免疫印迹; 小鼠; 图 6
  • 免疫印迹; 人类; 图 4
艾博抗(上海)贸易有限公司 Notch1抗体(Abcam, ab52627)被用于被用于免疫印迹在小鼠样本上 (图 6) 和 被用于免疫印迹在人类样本上 (图 4). EBioMedicine (2015) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 图 1
艾博抗(上海)贸易有限公司 Notch1抗体(Abcam, ab8925)被用于被用于免疫印迹在小鼠样本上 (图 1). Sci Rep (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 图 1
艾博抗(上海)贸易有限公司 Notch1抗体(Abcam, ab27526)被用于被用于免疫印迹在小鼠样本上 (图 1). Sci Rep (2016) ncbi
domestic rabbit 多克隆
  • 免疫细胞化学; 人类; 1:100; 图 1
  • 免疫印迹; 人类; 1:250; 图 1
  • 免疫组化; 小鼠; 1:100; 图 8
艾博抗(上海)贸易有限公司 Notch1抗体(Abcam, ab8925)被用于被用于免疫细胞化学在人类样本上浓度为1:100 (图 1), 被用于免疫印迹在人类样本上浓度为1:250 (图 1) 和 被用于免疫组化在小鼠样本上浓度为1:100 (图 8). Nat Commun (2016) ncbi
小鼠 单克隆(A6)
  • proximity ligation assay; 人类; 1:50; 图 5
  • 免疫组化; 小鼠; 1:25; 图 s11
艾博抗(上海)贸易有限公司 Notch1抗体(Abcam, ab44986)被用于被用于proximity ligation assay在人类样本上浓度为1:50 (图 5) 和 被用于免疫组化在小鼠样本上浓度为1:25 (图 s11). Nat Commun (2016) ncbi
domestic rabbit 单克隆(EP1238Y)
  • 免疫组化基因敲除验证; 小鼠; 图 4
  • 免疫组化-石蜡切片; 小鼠; 图 4
艾博抗(上海)贸易有限公司 Notch1抗体(Abcam, EP1238Y)被用于被用于免疫组化基因敲除验证在小鼠样本上 (图 4) 和 被用于免疫组化-石蜡切片在小鼠样本上 (图 4). Biochem Biophys Res Commun (2016) ncbi
domestic rabbit 单克隆(EP1238Y)
  • 免疫印迹; 人类; 1:1000; 图 2b
艾博抗(上海)贸易有限公司 Notch1抗体(Abcam, ab52627)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 2b). Mol Med Rep (2016) ncbi
domestic rabbit 单克隆(EP1238Y)
  • 免疫组化-石蜡切片; 人类; 图 3a
艾博抗(上海)贸易有限公司 Notch1抗体(Abcam, ab52627)被用于被用于免疫组化-石蜡切片在人类样本上 (图 3a). Oncotarget (2016) ncbi
domestic rabbit 单克隆(EP1238Y)
  • 免疫组化基因敲除验证; 小鼠; 图 3a
艾博抗(上海)贸易有限公司 Notch1抗体(Abcam, ab52627)被用于被用于免疫组化基因敲除验证在小鼠样本上 (图 3a). PLoS ONE (2015) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:1000; 图 3
艾博抗(上海)贸易有限公司 Notch1抗体(Abcam, ab52301)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 3). Nat Immunol (2016) ncbi
domestic rabbit 单克隆(EP1238Y)
  • 免疫细胞化学; 人类; 5.0 ug/ml
艾博抗(上海)贸易有限公司 Notch1抗体(Abcam, ab52627)被用于被用于免疫细胞化学在人类样本上浓度为5.0 ug/ml. PLoS ONE (2015) ncbi
domestic rabbit 单克隆(EP1238Y)
  • 免疫印迹; 人类; 1:5000
艾博抗(上海)贸易有限公司 Notch1抗体(Abcam, EP1238Y)被用于被用于免疫印迹在人类样本上浓度为1:5000. J Hematol Oncol (2015) ncbi
domestic rabbit 单克隆(EP1238Y)
  • 免疫印迹; 人类; 图 6a
艾博抗(上海)贸易有限公司 Notch1抗体(Abcam, ab52627)被用于被用于免疫印迹在人类样本上 (图 6a). Int J Mol Med (2015) ncbi
小鼠 单克隆(A6)
  • 免疫细胞化学; 人类; 1:30
艾博抗(上海)贸易有限公司 Notch1抗体(Abcam, ab44986)被用于被用于免疫细胞化学在人类样本上浓度为1:30. Am J Physiol Heart Circ Physiol (2014) ncbi
小鼠 单克隆(A6)
  • 免疫组化-石蜡切片; 人类; 1:200
艾博抗(上海)贸易有限公司 Notch1抗体(Abcam, ab44986)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:200. Clin Chim Acta (2014) ncbi
domestic rabbit 单克隆(EP1238Y)
  • 免疫印迹; 小鼠
艾博抗(上海)贸易有限公司 Notch1抗体(Abcam, ab52627)被用于被用于免疫印迹在小鼠样本上. PLoS ONE (2014) ncbi
domestic rabbit 单克隆(EP1238Y)
  • 免疫组化-石蜡切片; 人类; 1:200; 图 3c
艾博抗(上海)贸易有限公司 Notch1抗体(Abcam, EP1238Y)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:200 (图 3c). J Neurooncol (2014) ncbi
domestic rabbit 单克隆(EP1238Y)
  • 免疫组化-石蜡切片; 小鼠; 1:50
艾博抗(上海)贸易有限公司 Notch1抗体(Abcam, Ab52627)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:50. PLoS ONE (2013) ncbi
圣克鲁斯生物技术
小鼠 单克隆(mN1A)
  • 流式细胞仪; 人类; 图 2l
圣克鲁斯生物技术 Notch1抗体(Santa, sc32745)被用于被用于流式细胞仪在人类样本上 (图 2l). Br J Cancer (2019) ncbi
小鼠 单克隆(A-8)
  • 免疫印迹; 人类; 1:1000; 图 4a
圣克鲁斯生物技术 Notch1抗体(Santa Cruz, sc-376403)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 4a). Apoptosis (2017) ncbi
小鼠 单克隆(C-10)
  • 免疫印迹; 小鼠; 1:1000; 图 7b
  • 免疫细胞化学; 人类; 图 4b
  • 免疫印迹; 人类; 1:1000; 图 3b
圣克鲁斯生物技术 Notch1抗体(Santa Cruz, sc-373891)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 7b), 被用于免疫细胞化学在人类样本上 (图 4b) 和 被用于免疫印迹在人类样本上浓度为1:1000 (图 3b). Oncol Lett (2016) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 1:1500; 图 4
圣克鲁斯生物技术 Notch1抗体(Santa Cruz Biotechnology, sc-373944)被用于被用于免疫印迹在人类样本上浓度为1:1500 (图 4). Mol Med Rep (2016) ncbi
小鼠 单克隆(C-10)
  • 免疫印迹; 人类; 图 3c
圣克鲁斯生物技术 Notch1抗体(SantaCruz, sc-373891)被用于被用于免疫印迹在人类样本上 (图 3c). Mol Med Rep (2015) ncbi
小鼠 单克隆(mN1A)
  • 免疫印迹; 人类; 图 1b
圣克鲁斯生物技术 Notch1抗体(Santa Cruz, sc-32745)被用于被用于免疫印迹在人类样本上 (图 1b). Leukemia (2015) ncbi
小鼠 单克隆(C-10)
  • 免疫组化-石蜡切片; 小鼠; 1:50
圣克鲁斯生物技术 Notch1抗体(Santa Cruz Biotechnology, sc-373891)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:50. Int J Cancer (2014) ncbi
小鼠 单克隆(mN1A)
  • 免疫印迹; 小鼠; 1:500
圣克鲁斯生物技术 Notch1抗体(Santa Cruz Biotechnology, sc-32745)被用于被用于免疫印迹在小鼠样本上浓度为1:500. Mol Neurobiol (2014) ncbi
赛默飞世尔
小鼠 单克隆(MHN1-519)
  • 流式细胞仪; 人类; 1:50; 图 2a
赛默飞世尔 Notch1抗体(eBioscience, 17-9889)被用于被用于流式细胞仪在人类样本上浓度为1:50 (图 2a). Nat Cell Biol (2016) ncbi
小鼠 单克隆(A6)
  • 免疫组化; 人类; 1:500; 图 1
赛默飞世尔 Notch1抗体(Thermo Scientific, MS-1339)被用于被用于免疫组化在人类样本上浓度为1:500 (图 1). Stem Cell Res Ther (2016) ncbi
小鼠 单克隆(MHN1-519)
  • 流式细胞仪; 人类; 图 st1
赛默飞世尔 Notch1抗体(e- Bioscienc e, 17-9889-42)被用于被用于流式细胞仪在人类样本上 (图 st1). Exp Cell Res (2016) ncbi
小鼠 单克隆(mN1A)
  • 免疫沉淀; 人类
赛默飞世尔 Notch1抗体(eBioscience, mN1A)被用于被用于免疫沉淀在人类样本上. PLoS ONE (2013) ncbi
小鼠 单克隆(A6)
  • 抑制或激活实验; 小鼠
赛默飞世尔 Notch1抗体(Neomakers, A6)被用于被用于抑制或激活实验在小鼠样本上. Exp Cell Res (2005) ncbi
安迪生物R&D
家羊 多克隆
  • 流式细胞仪; 人类; 1:50; 图 2b
  • 免疫印迹; 人类; 1:250
安迪生物R&D Notch1抗体(R and D Systems, AF5267)被用于被用于流式细胞仪在人类样本上浓度为1:50 (图 2b) 和 被用于免疫印迹在人类样本上浓度为1:250. elife (2017) ncbi
家羊 多克隆
  • 流式细胞仪; 人类; 10 ug/ml; 图 1b
安迪生物R&D Notch1抗体(R&D Systems, AF5267)被用于被用于流式细胞仪在人类样本上浓度为10 ug/ml (图 1b). Science (2017) ncbi
家羊 多克隆
  • 免疫印迹; 人类; 1:200; 图 6
安迪生物R&D Notch1抗体(R&D Systems, AF3647)被用于被用于免疫印迹在人类样本上浓度为1:200 (图 6). Nat Commun (2016) ncbi
BioLegend
小鼠 单克隆(MHN1-519)
  • 流式细胞仪; 人类; 图 2b
BioLegend Notch1抗体(BioLegend, MHN1-519)被用于被用于流式细胞仪在人类样本上 (图 2b). Stem Cells Dev (2017) ncbi
Novus Biologicals
小鼠 单克隆(OTI3E12)
  • 免疫组化-石蜡切片; 人类; 图 1a
Novus Biologicals Notch1抗体(Novus Biologicals, 3E12)被用于被用于免疫组化-石蜡切片在人类样本上 (图 1a). Proc Natl Acad Sci U S A (2016) ncbi
小鼠 单克隆(mN1A)
  • 免疫印迹; 人类; 图 4
  • 免疫印迹; 小鼠; 图 6
Novus Biologicals Notch1抗体(Novus Biologicals, NB100-78,486)被用于被用于免疫印迹在人类样本上 (图 4) 和 被用于免疫印迹在小鼠样本上 (图 6). EBioMedicine (2015) ncbi
西格玛奥德里奇
小鼠 单克隆(3E12)
  • 免疫组化-石蜡切片; 人类; 图 1a
西格玛奥德里奇 Notch1抗体(Sigma, 3E12)被用于被用于免疫组化-石蜡切片在人类样本上 (图 1a). Sci Rep (2016) ncbi
小鼠 单克隆(mN1A)
  • 免疫印迹; 人类
西格玛奥德里奇 Notch1抗体(Sigma-Aldrich, N6786)被用于被用于免疫印迹在人类样本上. PLoS ONE (2014) ncbi
小鼠 单克隆(mN1A)
  • 免疫组化-石蜡切片; 小鼠; 1:50
西格玛奥德里奇 Notch1抗体(Cell Signaling, N6786)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:50. Int J Cancer (2014) ncbi
赛信通(上海)生物试剂有限公司
domestic rabbit 单克隆(D1E11)
  • 免疫印迹; 人类; 图 1d
赛信通(上海)生物试剂有限公司 Notch1抗体(cell signaling, 3608)被用于被用于免疫印迹在人类样本上 (图 1d). Oncogenesis (2020) ncbi
domestic rabbit 单克隆(D1E11)
  • 免疫印迹; 人类; 图 4c
赛信通(上海)生物试剂有限公司 Notch1抗体(Cell Signaling, 3608)被用于被用于免疫印迹在人类样本上 (图 4c). Sci Adv (2020) ncbi
domestic rabbit 单克隆(D3B8)
  • 免疫印迹; 人类; 图 4c
赛信通(上海)生物试剂有限公司 Notch1抗体(Cell Signaling, 4147)被用于被用于免疫印迹在人类样本上 (图 4c). Sci Adv (2020) ncbi
domestic rabbit 单克隆(D3B8)
  • 免疫组化-石蜡切片; 小鼠; 1:100; 图 1a
赛信通(上海)生物试剂有限公司 Notch1抗体(Cell Signaling, 4147)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:100 (图 1a). elife (2019) ncbi
domestic rabbit 单克隆(D3B8)
  • 免疫组化; 小鼠; 1:100; 图 3d
赛信通(上海)生物试剂有限公司 Notch1抗体(CST, 4147)被用于被用于免疫组化在小鼠样本上浓度为1:100 (图 3d). elife (2019) ncbi
domestic rabbit 单克隆(D6F11)
  • 免疫印迹; 人类; 图 2f
赛信通(上海)生物试剂有限公司 Notch1抗体(Cell Signaling, 4380T)被用于被用于免疫印迹在人类样本上 (图 2f). Cancer Cell Int (2019) ncbi
domestic rabbit 单克隆(D3B8)
  • 免疫印迹; 人类; 图 1e
赛信通(上海)生物试剂有限公司 Notch1抗体(Cell Signaling, 4147)被用于被用于免疫印迹在人类样本上 (图 1e). J Exp Med (2019) ncbi
domestic rabbit 单克隆(D1E11)
  • 免疫细胞化学; 人类; 1:100; 图 2i
  • 免疫组化; 人类; 1:200; 图 8b
  • 免疫印迹; 人类; 1:1000; 图 4h
赛信通(上海)生物试剂有限公司 Notch1抗体(Cell Signaling, 3608)被用于被用于免疫细胞化学在人类样本上浓度为1:100 (图 2i), 被用于免疫组化在人类样本上浓度为1:200 (图 8b) 和 被用于免疫印迹在人类样本上浓度为1:1000 (图 4h). Nat Neurosci (2019) ncbi
domestic rabbit 单克隆(D1E11)
  • 免疫印迹; 人类; 1:1000; 图 2c
赛信通(上海)生物试剂有限公司 Notch1抗体(Cell Signaling, 3608)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 2c). Nat Commun (2018) ncbi
domestic rabbit 单克隆(D3B8)
  • 免疫印迹; 人类; 图 6c
  • 免疫组化-石蜡切片; 小鼠; 图 5c
  • 免疫印迹; 小鼠; 图 5d
赛信通(上海)生物试剂有限公司 Notch1抗体(Cell Signaling, 4147)被用于被用于免疫印迹在人类样本上 (图 6c), 被用于免疫组化-石蜡切片在小鼠样本上 (图 5c) 和 被用于免疫印迹在小鼠样本上 (图 5d). J Clin Invest (2018) ncbi
domestic rabbit 单克隆(D3B8)
  • 免疫组化-石蜡切片; 人类; 1:150; 图 5a
赛信通(上海)生物试剂有限公司 Notch1抗体(Cell Signalling Technology, 4147)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:150 (图 5a). elife (2018) ncbi
domestic rabbit 单克隆(D3B8)
  • 免疫印迹; 人类; 图 s5j
赛信通(上海)生物试剂有限公司 Notch1抗体(Cell Signaling, 4147)被用于被用于免疫印迹在人类样本上 (图 s5j). Cell (2018) ncbi
domestic rabbit 单克隆(C44H11)
  • 其他; 人类; 图 4c
赛信通(上海)生物试剂有限公司 Notch1抗体(Cell Signaling, 3268)被用于被用于其他在人类样本上 (图 4c). Cancer Cell (2018) ncbi
domestic rabbit 单克隆(D3B8)
  • 免疫印迹; 小鼠; 1:1000; 图 2a
赛信通(上海)生物试剂有限公司 Notch1抗体(Cell Signaling, 4147)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 2a). J Exp Med (2018) ncbi
domestic rabbit 单克隆(D3B8)
  • 免疫印迹; 人类; 图 s3i
赛信通(上海)生物试剂有限公司 Notch1抗体(Cell Signaling, 4147)被用于被用于免疫印迹在人类样本上 (图 s3i). Cell (2018) ncbi
domestic rabbit 单克隆(D3B8)
  • 免疫印迹; 小鼠; 1:200; 图 1a
赛信通(上海)生物试剂有限公司 Notch1抗体(Cell Signaling, D3B8)被用于被用于免疫印迹在小鼠样本上浓度为1:200 (图 1a). J Immunol (2018) ncbi
domestic rabbit 单克隆(D6F11)
  • 免疫印迹; 人类; 1:1000; 图 s3a
赛信通(上海)生物试剂有限公司 Notch1抗体(Cell Signaling, 4380)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 s3a). Nat Commun (2017) ncbi
domestic rabbit 单克隆(D3B8)
  • 免疫印迹; 小鼠; 1:3000; 图 1b
赛信通(上海)生物试剂有限公司 Notch1抗体(Cell Signaling, 4147)被用于被用于免疫印迹在小鼠样本上浓度为1:3000 (图 1b). Nat Commun (2017) ncbi
domestic rabbit 单克隆(D6F11)
  • 免疫印迹; 小鼠; 1:500; 图 5b
赛信通(上海)生物试剂有限公司 Notch1抗体(CST, D6F11)被用于被用于免疫印迹在小鼠样本上浓度为1:500 (图 5b). Life Sci (2018) ncbi
domestic rabbit 单克隆(D3B8)
  • 免疫印迹; 人类; 1:1000; 图 1e
赛信通(上海)生物试剂有限公司 Notch1抗体(Cell Signaling, D3B8)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 1e). Nature (2017) ncbi
domestic rabbit 单克隆(D3B8)
  • 免疫印迹; 人类; 图 3e
赛信通(上海)生物试剂有限公司 Notch1抗体(Cell Signaling Technology, 4147)被用于被用于免疫印迹在人类样本上 (图 3e). Cancer Res (2017) ncbi
domestic rabbit 单克隆(D6F11)
  • 免疫印迹; 小鼠; 图 2c
赛信通(上海)生物试剂有限公司 Notch1抗体(Cell Signaling, 4380)被用于被用于免疫印迹在小鼠样本上 (图 2c). Nature (2017) ncbi
domestic rabbit 单克隆(D1E11)
  • 免疫印迹; 人类; 1:1000; 图 2a
赛信通(上海)生物试剂有限公司 Notch1抗体(CST, 3608)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 2a). J Cell Sci (2017) ncbi
domestic rabbit 单克隆(D6F11)
  • 免疫印迹; 大鼠; 1:1000; 图 1c
赛信通(上海)生物试剂有限公司 Notch1抗体(Cell Signaling, 4380)被用于被用于免疫印迹在大鼠样本上浓度为1:1000 (图 1c). World J Gastroenterol (2017) ncbi
domestic rabbit 单克隆(D6F11)
  • 免疫印迹基因敲除验证; 人类; 图 1-s1f
赛信通(上海)生物试剂有限公司 Notch1抗体(Cell signaling, D6F11)被用于被用于免疫印迹基因敲除验证在人类样本上 (图 1-s1f). elife (2017) ncbi
domestic rabbit 单克隆(D3B8)
  • 免疫印迹; 人类; 1:1000
赛信通(上海)生物试剂有限公司 Notch1抗体(Cell signaling, 4147)被用于被用于免疫印迹在人类样本上浓度为1:1000. elife (2017) ncbi
domestic rabbit 单克隆(C44H11)
  • reverse phase protein lysate microarray; 人类; 图 st6
赛信通(上海)生物试剂有限公司 Notch1抗体(CST, 3268)被用于被用于reverse phase protein lysate microarray在人类样本上 (图 st6). Cancer Cell (2017) ncbi
domestic rabbit 单克隆(D3B8)
  • 免疫组化; 大鼠; 1:100; 图 1e
  • 免疫印迹; 大鼠; 1:300; 图 1a
赛信通(上海)生物试剂有限公司 Notch1抗体(Cell Signaling, 4147)被用于被用于免疫组化在大鼠样本上浓度为1:100 (图 1e) 和 被用于免疫印迹在大鼠样本上浓度为1:300 (图 1a). BMC Neurosci (2017) ncbi
domestic rabbit 单克隆(D6F11)
  • 免疫细胞化学; 大鼠; 1:100; 图 4d
  • 免疫组化; 大鼠; 1:100; 图 1d
  • 免疫印迹; 大鼠; 1:500; 图 1a
赛信通(上海)生物试剂有限公司 Notch1抗体(Cell Signaling, 4380)被用于被用于免疫细胞化学在大鼠样本上浓度为1:100 (图 4d), 被用于免疫组化在大鼠样本上浓度为1:100 (图 1d) 和 被用于免疫印迹在大鼠样本上浓度为1:500 (图 1a). BMC Neurosci (2017) ncbi
domestic rabbit 单克隆(D1E11)
  • 免疫印迹; 人类; 图 5c
赛信通(上海)生物试剂有限公司 Notch1抗体(Cell Signaling, 3608)被用于被用于免疫印迹在人类样本上 (图 5c). Br J Cancer (2017) ncbi
domestic rabbit 单克隆(D3B8)
  • 免疫印迹; 人类; 图 5c
赛信通(上海)生物试剂有限公司 Notch1抗体(Cell Signaling, 4147)被用于被用于免疫印迹在人类样本上 (图 5c). Br J Cancer (2017) ncbi
domestic rabbit 单克隆(C44H11)
  • reverse phase protein lysate microarray; 人类; 图 3a
赛信通(上海)生物试剂有限公司 Notch1抗体(Cell Signaling, 3268)被用于被用于reverse phase protein lysate microarray在人类样本上 (图 3a). Nature (2017) ncbi
domestic rabbit 单克隆(D3B8)
  • 免疫印迹; 人类; 1:1000; 图 3g
赛信通(上海)生物试剂有限公司 Notch1抗体(cell signalling, 4147)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 3g). Nat Commun (2017) ncbi
domestic rabbit 单克隆(D1E11)
  • 免疫印迹; 人类; 1:1000; 图 s11a
赛信通(上海)生物试剂有限公司 Notch1抗体(Cell Signaling Technology, 3608)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 s11a). Nat Commun (2017) ncbi
domestic rabbit 单克隆(D3B8)
  • 免疫印迹; 小鼠; 1:200; 图 3c
赛信通(上海)生物试剂有限公司 Notch1抗体(Cell Signaling Technology, D3B8)被用于被用于免疫印迹在小鼠样本上浓度为1:200 (图 3c). J Clin Invest (2017) ncbi
domestic rabbit 单克隆(C44H11)
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司 Notch1抗体(Cell Signaling Technology, 3268)被用于被用于免疫印迹在人类样本上. Cell Syst (2017) ncbi
domestic rabbit 单克隆(D1E11)
  • 免疫印迹; 小鼠; 图 1b
赛信通(上海)生物试剂有限公司 Notch1抗体(Cell signaling, D1E11)被用于被用于免疫印迹在小鼠样本上 (图 1b). Nat Commun (2016) ncbi
domestic rabbit 单克隆(D1E11)
  • 免疫组化; 小鼠; 1:250; 图 3b
  • 免疫印迹; 小鼠; 1:2000; 图 3a
  • 免疫印迹; 人类; 1:2000; 图 4c
赛信通(上海)生物试剂有限公司 Notch1抗体(Cell signaling, 3608)被用于被用于免疫组化在小鼠样本上浓度为1:250 (图 3b), 被用于免疫印迹在小鼠样本上浓度为1:2000 (图 3a) 和 被用于免疫印迹在人类样本上浓度为1:2000 (图 4c). Neoplasia (2016) ncbi
domestic rabbit 单克隆(D3B8)
  • 免疫印迹; 人类; 图 4f
赛信通(上海)生物试剂有限公司 Notch1抗体(Cell Signaling, 4147P)被用于被用于免疫印迹在人类样本上 (图 4f). PLoS Pathog (2016) ncbi
domestic rabbit 单克隆(D1E11)
  • 免疫组化-冰冻切片; 小鼠; 1:1000; 图 3b
赛信通(上海)生物试剂有限公司 Notch1抗体(Cell Signaling, D1E11)被用于被用于免疫组化-冰冻切片在小鼠样本上浓度为1:1000 (图 3b). Proc Natl Acad Sci U S A (2016) ncbi
domestic rabbit 单克隆(D3B8)
  • 免疫组化-冰冻切片; 小鼠; 1:1000; 图 3c
赛信通(上海)生物试剂有限公司 Notch1抗体(Cell Signaling, D3B8)被用于被用于免疫组化-冰冻切片在小鼠样本上浓度为1:1000 (图 3c). Proc Natl Acad Sci U S A (2016) ncbi
domestic rabbit 单克隆(D3B8)
  • 免疫印迹; 人类; 1:500; 图 3
赛信通(上海)生物试剂有限公司 Notch1抗体(Cell Signaling, 4147)被用于被用于免疫印迹在人类样本上浓度为1:500 (图 3). Oncol Lett (2016) ncbi
domestic rabbit 单克隆(C37C7)
  • 免疫组化-石蜡切片; 人类; 图 s4
赛信通(上海)生物试剂有限公司 Notch1抗体(Cell Signaling, C37C7)被用于被用于免疫组化-石蜡切片在人类样本上 (图 s4). Proc Natl Acad Sci U S A (2016) ncbi
domestic rabbit 单克隆(D3B8)
  • 免疫印迹; 人类; 图 s3
赛信通(上海)生物试剂有限公司 Notch1抗体(Cell Signaling, D3B8)被用于被用于免疫印迹在人类样本上 (图 s3). Proc Natl Acad Sci U S A (2016) ncbi
domestic rabbit 单克隆(D3B8)
  • 免疫印迹; 人类; 1:800; 图 1b
赛信通(上海)生物试剂有限公司 Notch1抗体(Cell Signaling, 4147)被用于被用于免疫印迹在人类样本上浓度为1:800 (图 1b). Oncotarget (2016) ncbi
domestic rabbit 单克隆(D6F11)
  • 免疫印迹; 人类; 1:1000; 图 3a
赛信通(上海)生物试剂有限公司 Notch1抗体(cell signalling, 4380)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 3a). Oncotarget (2016) ncbi
domestic rabbit 单克隆(C44H11)
  • 免疫印迹; 人类; 1:1000; 图 s3
赛信通(上海)生物试剂有限公司 Notch1抗体(cell signalling, 3268)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 s3). Nat Commun (2016) ncbi
domestic rabbit 单克隆(D3B8)
  • 免疫印迹; 人类; 图 1
赛信通(上海)生物试剂有限公司 Notch1抗体(Cell signaling, 4147)被用于被用于免疫印迹在人类样本上 (图 1). Nucleic Acids Res (2016) ncbi
domestic rabbit 单克隆(D1E11)
  • 免疫细胞化学; 人类; 图 e6a
赛信通(上海)生物试剂有限公司 Notch1抗体(Cell Signaling Technology, D1E11)被用于被用于免疫细胞化学在人类样本上 (图 e6a). Nature (2016) ncbi
domestic rabbit 单克隆(D6F11)
  • 免疫印迹; 人类; 1:1000; 图 2e
赛信通(上海)生物试剂有限公司 Notch1抗体(Cell signaling, 4380)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 2e). Nat Cell Biol (2016) ncbi
domestic rabbit 单克隆(D3B8)
  • 免疫印迹; 人类; 1:500; 图 2b
赛信通(上海)生物试剂有限公司 Notch1抗体(Cell signaling, 4147)被用于被用于免疫印迹在人类样本上浓度为1:500 (图 2b). Nat Cell Biol (2016) ncbi
domestic rabbit 单克隆(D1E11)
  • 免疫组化-石蜡切片; 小鼠; 1:200; 图 6a
赛信通(上海)生物试剂有限公司 Notch1抗体(Cell signaling, 3608)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:200 (图 6a). Nat Cell Biol (2016) ncbi
domestic rabbit 单克隆(D1E11)
  • 免疫印迹; 人类; 图 6d
赛信通(上海)生物试剂有限公司 Notch1抗体(Cell Signaling, 3608)被用于被用于免疫印迹在人类样本上 (图 6d). Biochem Pharmacol (2016) ncbi
domestic rabbit 单克隆(D3B8)
  • 免疫印迹; 小鼠; 图 7d
赛信通(上海)生物试剂有限公司 Notch1抗体(Cell Signaling Technology, 4147S)被用于被用于免疫印迹在小鼠样本上 (图 7d). elife (2016) ncbi
domestic rabbit 单克隆(D6F11)
  • 免疫印迹; 人类; 1:1000; 图 3
赛信通(上海)生物试剂有限公司 Notch1抗体(Cell Signaling Tech, D6F11)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 3). Sci Rep (2016) ncbi
domestic rabbit 单克隆(D3B8)
  • 免疫印迹; 人类; 1:1000; 图 1
赛信通(上海)生物试剂有限公司 Notch1抗体(Cell Signaling Tech, D3B8)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 1). Sci Rep (2016) ncbi
domestic rabbit 单克隆(D1E11)
  • 免疫印迹; 人类; 1:1000; 图 6
赛信通(上海)生物试剂有限公司 Notch1抗体(Cell Signaling, 3608)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 6). Stem Cell Reports (2016) ncbi
domestic rabbit 单克隆(D3B8)
  • 免疫印迹; 人类; 1:1000; 图 4d
赛信通(上海)生物试剂有限公司 Notch1抗体(Cell Signaling, 4147)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 4d). Int J Cancer (2016) ncbi
domestic rabbit 单克隆(D1E11)
  • 免疫细胞化学; 大鼠; 1:200; 图 3b
  • 免疫印迹; 大鼠; 1:1000; 图 3a
赛信通(上海)生物试剂有限公司 Notch1抗体(CST, 3608)被用于被用于免疫细胞化学在大鼠样本上浓度为1:200 (图 3b) 和 被用于免疫印迹在大鼠样本上浓度为1:1000 (图 3a). Cell Cycle (2016) ncbi
domestic rabbit 单克隆(D3B8)
  • 免疫印迹; 小鼠; 图 s2
赛信通(上海)生物试剂有限公司 Notch1抗体(Cell Signaling, 4147)被用于被用于免疫印迹在小鼠样本上 (图 s2). Biol Open (2016) ncbi
domestic rabbit 单克隆(D3B8)
  • 免疫印迹; 小鼠; 1:1000; 图 5
赛信通(上海)生物试剂有限公司 Notch1抗体(Cell Signaling, 4147p)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 5). Front Cell Neurosci (2016) ncbi
domestic rabbit 单克隆(D3B8)
  • 免疫印迹; 人类; 图 4
赛信通(上海)生物试剂有限公司 Notch1抗体(Cell Signaling, 4147)被用于被用于免疫印迹在人类样本上 (图 4). Oncotarget (2016) ncbi
domestic rabbit 单克隆(D3B8)
  • 免疫组化-冰冻切片; 小鼠; 1:100; 图 6
  • 免疫印迹; 小鼠; 1:1000; 图 6
赛信通(上海)生物试剂有限公司 Notch1抗体(Cell signaling, 4147)被用于被用于免疫组化-冰冻切片在小鼠样本上浓度为1:100 (图 6) 和 被用于免疫印迹在小鼠样本上浓度为1:1000 (图 6). Nat Commun (2016) ncbi
domestic rabbit 单克隆(D3B8)
  • 免疫组化; 人类; 1:100; 图 4
赛信通(上海)生物试剂有限公司 Notch1抗体(Cell Signaling Technology, 4147)被用于被用于免疫组化在人类样本上浓度为1:100 (图 4). Nat Genet (2016) ncbi
domestic rabbit 单克隆(D3B8)
  • 免疫印迹; 人类; 1:500; 图 2, 3
赛信通(上海)生物试剂有限公司 Notch1抗体(Cell Signaling, 4147)被用于被用于免疫印迹在人类样本上浓度为1:500 (图 2, 3). J Neurosci (2016) ncbi
domestic rabbit 单克隆(D3B8)
  • 免疫印迹; 人类; 图 5
赛信通(上海)生物试剂有限公司 Notch1抗体(Cell Signaling Technology, 4147)被用于被用于免疫印迹在人类样本上 (图 5). Oncotarget (2016) ncbi
domestic rabbit 单克隆(D1E11)
  • 免疫印迹; 人类; 图 6
赛信通(上海)生物试剂有限公司 Notch1抗体(Cell Signaling Tech, 3608)被用于被用于免疫印迹在人类样本上 (图 6). Oncotarget (2016) ncbi
domestic rabbit 单克隆(D3B8)
  • 免疫印迹; 人类; 图 1
赛信通(上海)生物试剂有限公司 Notch1抗体(Cell Signaling Tech, 4147)被用于被用于免疫印迹在人类样本上 (图 1). Oncotarget (2016) ncbi
domestic rabbit 单克隆(D3B8)
  • 免疫印迹; 仓鼠
赛信通(上海)生物试剂有限公司 Notch1抗体(Cell Signaling, 4147)被用于被用于免疫印迹在仓鼠样本上. Proc Natl Acad Sci U S A (2016) ncbi
domestic rabbit 单克隆(D1E11)
  • 免疫印迹; 大鼠; 图 2
赛信通(上海)生物试剂有限公司 Notch1抗体(Cell Signaling Technology, 3608)被用于被用于免疫印迹在大鼠样本上 (图 2). Oncotarget (2015) ncbi
domestic rabbit 单克隆(D3B8)
  • 免疫细胞化学; 人类; 图 5d
  • 免疫印迹; 人类; 图 5b
赛信通(上海)生物试剂有限公司 Notch1抗体(Cell Signaling, 4147)被用于被用于免疫细胞化学在人类样本上 (图 5d) 和 被用于免疫印迹在人类样本上 (图 5b). Oncotarget (2015) ncbi
domestic rabbit 单克隆(D6F11)
  • 免疫印迹; 人类; 图 5b
赛信通(上海)生物试剂有限公司 Notch1抗体(Cell Signaling, 4380)被用于被用于免疫印迹在人类样本上 (图 5b). Oncotarget (2015) ncbi
domestic rabbit 单克隆(C44H11)
  • 免疫组化-石蜡切片; 人类; 1:200; 图 S1
  • 免疫印迹; 人类; 1:2000; 图 5A
赛信通(上海)生物试剂有限公司 Notch1抗体(Cell signaling, C44H11)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:200 (图 S1) 和 被用于免疫印迹在人类样本上浓度为1:2000 (图 5A). Am J Pathol (2015) ncbi
domestic rabbit 单克隆(D3B8)
  • 免疫印迹; 小鼠; 1:1000; 图 s7d
赛信通(上海)生物试剂有限公司 Notch1抗体(Cell Signaling technologies, 4147)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 s7d). Nat Med (2015) ncbi
domestic rabbit 单克隆(D3B8)
  • 免疫印迹; 人类; 1:1000; 图 5a
赛信通(上海)生物试剂有限公司 Notch1抗体(Cell Signaling Technology, D3B8)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 5a). PLoS Genet (2015) ncbi
domestic rabbit 单克隆(D6F11)
  • 免疫印迹; 人类; 1:1000; 图 5a
赛信通(上海)生物试剂有限公司 Notch1抗体(Cell Signaling Technology,, D6F11)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 5a). PLoS Genet (2015) ncbi
domestic rabbit 单克隆(D3B8)
  • 免疫印迹; 人类; 图 8
赛信通(上海)生物试剂有限公司 Notch1抗体(Cell Signalling, 4147S)被用于被用于免疫印迹在人类样本上 (图 8). PLoS ONE (2015) ncbi
domestic rabbit 单克隆(D1E11)
  • 免疫组化-冰冻切片; 小鼠; 1:200; 图 3
赛信通(上海)生物试剂有限公司 Notch1抗体(Cell Signaling, 3608)被用于被用于免疫组化-冰冻切片在小鼠样本上浓度为1:200 (图 3). Development (2015) ncbi
domestic rabbit 单克隆(D3B8)
  • 免疫印迹; 小鼠; 图 9a
赛信通(上海)生物试剂有限公司 Notch1抗体(Cell Signaling Technology, 4147)被用于被用于免疫印迹在小鼠样本上 (图 9a). J Cell Biol (2015) ncbi
domestic rabbit 单克隆(D1E11)
  • 免疫组化-石蜡切片; 人类; 1:25
赛信通(上海)生物试剂有限公司 Notch1抗体(Cell Signaling, 3608)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:25. Oncotarget (2015) ncbi
domestic rabbit 单克隆(D1E11)
  • 免疫印迹; 人类; 图 f4
  • 免疫印迹; 小鼠; 图 f6
赛信通(上海)生物试剂有限公司 Notch1抗体(cell signaling technology, 3608S)被用于被用于免疫印迹在人类样本上 (图 f4) 和 被用于免疫印迹在小鼠样本上 (图 f6). Oncotarget (2015) ncbi
domestic rabbit 单克隆(D6F11)
  • 免疫印迹; 人类; 1:2000
赛信通(上海)生物试剂有限公司 Notch1抗体(Cell Signaling, 4380)被用于被用于免疫印迹在人类样本上浓度为1:2000. PLoS ONE (2015) ncbi
domestic rabbit 单克隆(D3B8)
  • 免疫印迹; 人类; 图 s4
赛信通(上海)生物试剂有限公司 Notch1抗体(Cell Signaling, 4147)被用于被用于免疫印迹在人类样本上 (图 s4). Oncotarget (2015) ncbi
domestic rabbit 单克隆(D3B8)
  • 免疫印迹; 人类; 1:500
赛信通(上海)生物试剂有限公司 Notch1抗体(Cell Signaling Technology, D3B8)被用于被用于免疫印迹在人类样本上浓度为1:500. J Hematol Oncol (2015) ncbi
domestic rabbit 单克隆(D3B8)
  • 免疫组化-冰冻切片; 人类; 1:100
  • 免疫印迹; 人类; 1:800
赛信通(上海)生物试剂有限公司 Notch1抗体(Cell Signaling, 4147)被用于被用于免疫组化-冰冻切片在人类样本上浓度为1:100 和 被用于免疫印迹在人类样本上浓度为1:800. Oncotarget (2015) ncbi
domestic rabbit 单克隆(D6F11)
  • 免疫印迹; 人类; 图 5a
赛信通(上海)生物试剂有限公司 Notch1抗体(Cell Signaling Technology Inc., 4380)被用于被用于免疫印迹在人类样本上 (图 5a). Mol Carcinog (2015) ncbi
domestic rabbit 单克隆(D6F11)
  • 免疫印迹; 人类; 图 1
赛信通(上海)生物试剂有限公司 Notch1抗体(Cell Signaling, 4380)被用于被用于免疫印迹在人类样本上 (图 1). Oncotarget (2015) ncbi
domestic rabbit 单克隆(D1E11)
  • 染色质免疫沉淀 ; 小鼠; 图 1
赛信通(上海)生物试剂有限公司 Notch1抗体(Cell Signaling, D1E11)被用于被用于染色质免疫沉淀 在小鼠样本上 (图 1). J Immunol (2015) ncbi
domestic rabbit 单克隆(C44H11)
  • 免疫印迹; 人类; 1:1,000
赛信通(上海)生物试剂有限公司 Notch1抗体(Cell Signaling, 3268s)被用于被用于免疫印迹在人类样本上浓度为1:1,000. Am J Physiol Heart Circ Physiol (2014) ncbi
domestic rabbit 单克隆(D3B8)
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司 Notch1抗体(Cell Signaling Technology, 4147)被用于被用于免疫印迹在人类样本上. PLoS ONE (2014) ncbi
domestic rabbit 单克隆(D6F11)
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司 Notch1抗体(Cell Signaling Technology, 4380)被用于被用于免疫印迹在人类样本上. PLoS ONE (2014) ncbi
大鼠 单克隆(5B5)
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司 Notch1抗体(Cell Signaling, 5B5)被用于被用于免疫印迹在人类样本上. Cancer Res (2014) ncbi
domestic rabbit 单克隆(D3B8)
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司 Notch1抗体(Cell Signaling, 4147)被用于被用于免疫印迹在人类样本上. J Natl Cancer Inst (2014) ncbi
domestic rabbit 单克隆(D3B8)
  • 染色质免疫沉淀 ; 小鼠
赛信通(上海)生物试剂有限公司 Notch1抗体(Cell Signalling, 4147)被用于被用于染色质免疫沉淀 在小鼠样本上. Leukemia (2014) ncbi
domestic rabbit 单克隆(D1E11)
  • 免疫组化-石蜡切片; 人类
  • 免疫组化-石蜡切片; 大鼠
赛信通(上海)生物试剂有限公司 Notch1抗体(Cell Signaling Technology, D1E11)被用于被用于免疫组化-石蜡切片在人类样本上 和 被用于免疫组化-石蜡切片在大鼠样本上. Lab Invest (2013) ncbi
domestic rabbit 单克隆(D3B8)
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司 Notch1抗体(Cell Signaling Technology, D3B8)被用于被用于免疫印迹在人类样本上. Lab Invest (2013) ncbi
domestic rabbit 单克隆(C44H11)
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司 Notch1抗体(Cell Signaling Technology, C44H11)被用于被用于免疫印迹在人类样本上. Lab Invest (2013) ncbi
domestic rabbit 单克隆(D1E11)
  • 免疫组化; 人类; 1:100
赛信通(上海)生物试剂有限公司 Notch1抗体(细胞, 3608)被用于被用于免疫组化在人类样本上浓度为1:100. Neuro Oncol (2013) ncbi
domestic rabbit 单克隆(D6F11)
  • 免疫细胞化学; 猪; 1:200
  • 免疫印迹; 猪; 1:1000
赛信通(上海)生物试剂有限公司 Notch1抗体(Cell Signaling Technology, 4380)被用于被用于免疫细胞化学在猪样本上浓度为1:200 和 被用于免疫印迹在猪样本上浓度为1:1000. Cell Signal (2013) ncbi
domestic rabbit 单克隆(D1E11)
  • 免疫组化-石蜡切片; 人类; 0.7 ug/ml
赛信通(上海)生物试剂有限公司 Notch1抗体(Cell Signaling Technology, D1E11)被用于被用于免疫组化-石蜡切片在人类样本上浓度为0.7 ug/ml. Am J Pathol (2012) ncbi
Developmental Studies Hybridoma Bank
大鼠 单克隆(bTAN 20)
  • 免疫印迹; 人类
Developmental Studies Hybridoma Bank Notch1抗体(DSHB, bTAN20)被用于被用于免疫印迹在人类样本上. Int J Cancer (2018) ncbi
大鼠 单克隆(bTAN 20)
  • 免疫印迹; 小鼠; 图 2b
Developmental Studies Hybridoma Bank Notch1抗体(DSHB, bTAN 20)被用于被用于免疫印迹在小鼠样本上 (图 2b). Cell Death Dis (2016) ncbi
默克密理博中国
domestic rabbit 多克隆
  • 免疫印迹; 大鼠; 1:200; 图 2e
默克密理博中国 Notch1抗体(Millipore, 07-1232)被用于被用于免疫印迹在大鼠样本上浓度为1:200 (图 2e). Hypertens Res (2017) ncbi
文章列表
  1. Chandrasekaran B, Dahiya N, Tyagi A, Kolluru V, Saran U, Baby B, et al. Chronic exposure to cadmium induces a malignant transformation of benign prostate epithelial cells. Oncogenesis. 2020;9:23 pubmed 出版商
  2. Liu H, Mei F, Yang W, Wang H, Wong E, Cai J, et al. Epac1 inhibition ameliorates pathological angiogenesis through coordinated activation of Notch and suppression of VEGF signaling. Sci Adv. 2020;6:eaay3566 pubmed 出版商
  3. Travisano S, Oliveira V, Prados B, Grego Bessa J, Piñeiro Sabarís R, Bou V, et al. Coronary arterial development is regulated by a Dll4-Jag1-EphrinB2 signaling cascade. elife. 2019;8: pubmed 出版商
  4. Stupnikov M, Yang Y, Mori M, LU J, Cardoso W. Jagged and Delta-like ligands control distinct events during airway progenitor cell differentiation. elife. 2019;8: pubmed 出版商
  5. Capulli M, Hristova D, Valbret Z, Carys K, Arjan R, Maurizi A, et al. Notch2 pathway mediates breast cancer cellular dormancy and mobilisation in bone and contributes to haematopoietic stem cell mimicry. Br J Cancer. 2019;121:157-171 pubmed 出版商
  6. He W, Tang J, Li W, Li Y, Mei Y, He L, et al. Mutual regulation of JAG2 and PRAF2 promotes migration and invasion of colorectal cancer cells uncoupled from epithelial-mesenchymal transition. Cancer Cell Int. 2019;19:160 pubmed 出版商
  7. Wu K, Zou J, Lin C, Jie Z. MicroRNA-140-5p inhibits cell proliferation, migration and promotes cell apoptosis in gastric cancer through the negative regulation of THY1-mediated Notch signaling. Biosci Rep. 2019;: pubmed 出版商
  8. Liu Y, Wang X, Deng L, Ping L, Shi Y, Zheng W, et al. ITK inhibition induced in vitro and in vivo anti-tumor activity through downregulating TCR signaling pathway in malignant T cell lymphoma. Cancer Cell Int. 2019;19:32 pubmed 出版商
  9. Xia P, Gütl D, Zheden V, Heisenberg C. Lateral Inhibition in Cell Specification Mediated by Mechanical Signals Modulating TAZ Activity. Cell. 2019;176:1379-1392.e14 pubmed 出版商
  10. Chen H, Poran A, Unni A, Huang S, Elemento O, Snoeck H, et al. Generation of pulmonary neuroendocrine cells and SCLC-like tumors from human embryonic stem cells. J Exp Med. 2019;216:674-687 pubmed 出版商
  11. Wang J, Xu S, Duan J, Yi L, Guo Y, Shi Y, et al. Invasion of white matter tracts by glioma stem cells is regulated by a NOTCH1-SOX2 positive-feedback loop. Nat Neurosci. 2019;22:91-105 pubmed 出版商
  12. Mangolini M, Götte F, Moore A, Ammon T, Oelsner M, Lutzny Geier G, et al. Notch2 controls non-autonomous Wnt-signalling in chronic lymphocytic leukaemia. Nat Commun. 2018;9:3839 pubmed 出版商
  13. Li L, Guturi K, Gautreau B, Patel P, Saad A, Morii M, et al. Ubiquitin ligase RNF8 suppresses Notch signaling to regulate mammary development and tumorigenesis. J Clin Invest. 2018;128:4525-4542 pubmed 出版商
  14. Eley L, Alqahtani A, MacGrogan D, Richardson R, Murphy L, Salguero Jimenez A, et al. A novel source of arterial valve cells linked to bicuspid aortic valve without raphe in mice. elife. 2018;7: pubmed 出版商
  15. Chakrabarti R, Celià Terrassa T, Kumar S, Hang X, Wei Y, Choudhury A, et al. Notch ligand Dll1 mediates cross-talk between mammary stem cells and the macrophageal niche. Science. 2018;360: pubmed 出版商
  16. Pan B, Wu L, Pan L, Yang Y, Li H, Dai Y, et al. Up-regulation of microRNA-340 promotes osteosarcoma cell apoptosis while suppressing proliferation, migration, and invasion by inactivating the CTNNB1-mediated Notch signaling pathway. Biosci Rep. 2018;38: pubmed 出版商
  17. Das A, Huang G, Bonkowski M, Longchamp A, Li C, Schultz M, et al. Impairment of an Endothelial NAD+-H2S Signaling Network Is a Reversible Cause of Vascular Aging. Cell. 2018;173:74-89.e20 pubmed 出版商
  18. Ng P, Li J, Jeong K, Shao S, Chen H, Tsang Y, et al. Systematic Functional Annotation of Somatic Mutations in Cancer. Cancer Cell. 2018;33:450-462.e10 pubmed 出版商
  19. Baldoni S, Del Papa B, Dorillo E, Aureli P, De Falco F, Rompietti C, et al. Bepridil exhibits anti-leukemic activity associated with NOTCH1 pathway inhibition in chronic lymphocytic leukemia. Int J Cancer. 2018;143:958-970 pubmed 出版商
  20. Hu X, Das B, Hou H, He W, Yan R. BACE1 deletion in the adult mouse reverses preformed amyloid deposition and improves cognitive functions. J Exp Med. 2018;215:927-940 pubmed 出版商
  21. Nandagopal N, Santat L, Lebon L, Sprinzak D, Bronner M, Elowitz M. Dynamic Ligand Discrimination in the Notch Signaling Pathway. Cell. 2018;172:869-880.e19 pubmed 出版商
  22. Steinbuck M, Arakcheeva K, Winandy S. Novel TCR-Mediated Mechanisms of Notch Activation and Signaling. J Immunol. 2018;200:997-1007 pubmed 出版商
  23. Bhardwaj A, Yang Y, Ueberheide B, Smith S. Whole proteome analysis of human tankyrase knockout cells reveals targets of tankyrase-mediated degradation. Nat Commun. 2017;8:2214 pubmed 出版商
  24. Fang J, Coon B, Gillis N, Chen Z, Qiu J, Chittenden T, et al. Shear-induced Notch-Cx37-p27 axis arrests endothelial cell cycle to enable arterial specification. Nat Commun. 2017;8:2149 pubmed 出版商
  25. Ma Q, Wang Y, Zhang T, Zuo W. Notch-mediated Sox9+ cell activation contributes to kidney repair after partial nephrectomy. Life Sci. 2018;193:104-109 pubmed 出版商
  26. Polacheck W, Kutys M, Yang J, Eyckmans J, Wu Y, Vasavada H, et al. A non-canonical Notch complex regulates adherens junctions and vascular barrier function. Nature. 2017;552:258-262 pubmed 出版商
  27. Nakagawa N, Li J, Yabuno Nakagawa K, Eom T, Cowles M, Mapp T, et al. APC sets the Wnt tone necessary for cerebral cortical progenitor development. Genes Dev. 2017;31:1679-1692 pubmed 出版商
  28. Jin L, Vu T, Yuan G, Datta P. STRAP Promotes Stemness of Human Colorectal Cancer via Epigenetic Regulation of the NOTCH Pathway. Cancer Res. 2017;77:5464-5478 pubmed 出版商
  29. Lim J, Ibaseta A, Fischer M, Cancilla B, O Young G, Cristea S, et al. Intratumoural heterogeneity generated by Notch signalling promotes small-cell lung cancer. Nature. 2017;545:360-364 pubmed 出版商
  30. Frank S, Berger P, Ljungman M, Miranti C. Human prostate luminal cell differentiation requires NOTCH3 induction by p38-MAPK and MYC. J Cell Sci. 2017;130:1952-1964 pubmed 出版商
  31. Lian W, Zhang L, Yang L, Chen W. AP-2α reverses vincristine-induced multidrug resistance of SGC7901 gastric cancer cells by inhibiting the Notch pathway. Apoptosis. 2017;22:933-941 pubmed 出版商
  32. Zhu X, Yuan X, Wang M, Fang Y, Liu Y, Zhang X, et al. A Wnt/Notch/Pax7 signaling network supports tissue integrity in tongue development. J Biol Chem. 2017;292:9409-9419 pubmed 出版商
  33. Wang Y, Shen R, Han B, Li Z, Xiong L, Zhang F, et al. Notch signaling mediated by TGF-?/Smad pathway in concanavalin A-induced liver fibrosis in rats. World J Gastroenterol. 2017;23:2330-2336 pubmed 出版商
  34. Sawaguchi S, Varshney S, Ogawa M, Sakaidani Y, Yagi H, Takeshita K, et al. O-GlcNAc on NOTCH1 EGF repeats regulates ligand-induced Notch signaling and vascular development in mammals. elife. 2017;6: pubmed 出版商
  35. Cherniack A, Shen H, Walter V, Stewart C, Murray B, Bowlby R, et al. Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell. 2017;31:411-423 pubmed 出版商
  36. Zeng W, Han Y, Zhu G, Huang L, Deng Y, Wang Q, et al. Hypertonic saline attenuates expression of Notch signaling and proinflammatory mediators in activated microglia in experimentally induced cerebral ischemia and hypoxic BV-2 microglia. BMC Neurosci. 2017;18:32 pubmed 出版商
  37. Puhakka N, Bot A, Vuokila N, Dębski K, Lukasiuk K, Pitkanen A. Chronically dysregulated NOTCH1 interactome in the dentate gyrus after traumatic brain injury. PLoS ONE. 2017;12:e0172521 pubmed 出版商
  38. Luca V, Kim B, Ge C, Kakuda S, Wu D, Roein Peikar M, et al. Notch-Jagged complex structure implicates a catch bond in tuning ligand sensitivity. Science. 2017;355:1320-1324 pubmed 出版商
  39. Mandl M, Zhang S, Ulrich M, Schmoeckel E, Mayr D, Vollmar A, et al. Inhibition of Cdk5 induces cell death of tumor-initiating cells. Br J Cancer. 2017;116:912-922 pubmed 出版商
  40. Delhove J, Buckley S, Perocheau D, Karda R, Arbuthnot P, Henderson N, et al. Longitudinal in vivo bioimaging of hepatocyte transcription factor activity following cholestatic liver injury in mice. Sci Rep. 2017;7:41874 pubmed 出版商
  41. García Heredia J, Lucena Cacace A, Verdugo Sivianes E, Pérez M, Carnero A. The Cargo Protein MAP17 (PDZK1IP1) Regulates the Cancer Stem Cell Pool Activating the Notch Pathway by Abducting NUMB. Clin Cancer Res. 2017;23:3871-3883 pubmed 出版商
  42. . Integrated genomic and molecular characterization of cervical cancer. Nature. 2017;543:378-384 pubmed 出版商
  43. Chorzalska A, Kim J, Roder K, Tepper A, Ahsan N, Rao R, et al. Long-Term Exposure to Imatinib Mesylate Downregulates Hippo Pathway and Activates YAP in a Model of Chronic Myelogenous Leukemia. Stem Cells Dev. 2017;26:656-677 pubmed 出版商
  44. Yue F, Bi P, Wang C, Shan T, Nie Y, Ratliff T, et al. Pten is necessary for the quiescence and maintenance of adult muscle stem cells. Nat Commun. 2017;8:14328 pubmed 出版商
  45. Xu J, Zhou W, Yang F, Chen G, Li H, Zhao Y, et al. The β-TrCP-FBXW2-SKP2 axis regulates lung cancer cell growth with FBXW2 acting as a tumour suppressor. Nat Commun. 2017;8:14002 pubmed 出版商
  46. Hurst L, Dunmore B, Long L, Crosby A, Al Lamki R, Deighton J, et al. TNFα drives pulmonary arterial hypertension by suppressing the BMP type-II receptor and altering NOTCH signalling. Nat Commun. 2017;8:14079 pubmed 出版商
  47. Hirai M, Arita Y, McGlade C, Lee K, Chen J, Evans S. Adaptor proteins NUMB and NUMBL promote cell cycle withdrawal by targeting ERBB2 for degradation. J Clin Invest. 2017;127:569-582 pubmed 出版商
  48. Hill S, Nesser N, Johnson Camacho K, Jeffress M, Johnson A, Boniface C, et al. Context Specificity in Causal Signaling Networks Revealed by Phosphoprotein Profiling. Cell Syst. 2017;4:73-83.e10 pubmed 出版商
  49. Revandkar A, Perciato M, Toso A, Alajati A, Chen J, Gerber H, et al. Inhibition of Notch pathway arrests PTEN-deficient advanced prostate cancer by triggering p27-driven cellular senescence. Nat Commun. 2016;7:13719 pubmed 出版商
  50. Li F, Li Z, Jiang Z, Tian Y, Wang Z, Yi W, et al. Enhancement of early cardiac differentiation of dedifferentiated fat cells by dimethyloxalylglycine via notch signaling pathway. Am J Transl Res. 2016;8:4791-4801 pubmed
  51. Xiao Y, Yang X, Miao Y, He X, Wang M, Sha W. Inhibition of cell proliferation and tumor growth of colorectal cancer by inhibitors of Wnt and Notch signaling pathways. Oncol Lett. 2016;12:3695-3700 pubmed
  52. Kim W, Khan S, Gvozdenovic Jeremic J, Kim Y, Dahlman J, Kim H, et al. Hippo signaling interactions with Wnt/?-catenin and Notch signaling repress liver tumorigenesis. J Clin Invest. 2017;127:137-152 pubmed 出版商
  53. Pamarthy S, Mao L, Katara G, Fleetwood S, Kulshreshta A, Gilman Sachs A, et al. The V-ATPase a2 isoform controls mammary gland development through Notch and TGF-β signaling. Cell Death Dis. 2016;7:e2443 pubmed 出版商
  54. Zhang Q, Zhang Y, Parsels J, Lohse I, Lawrence T, Pasca di Magliano M, et al. Fbxw7 Deletion Accelerates KrasG12D-Driven Pancreatic Tumorigenesis via Yap Accumulation. Neoplasia. 2016;18:666-673 pubmed 出版商
  55. Li S, Hu H, He Z, Liang D, Sun R, Lan K. Fine-Tuning of the Kaposi's Sarcoma-Associated Herpesvirus Life Cycle in Neighboring Cells through the RTA-JAG1-Notch Pathway. PLoS Pathog. 2016;12:e1005900 pubmed 出版商
  56. Kuzmanov U, Guo H, Buchsbaum D, Cosme J, Abbasi C, Isserlin R, et al. Global phosphoproteomic profiling reveals perturbed signaling in a mouse model of dilated cardiomyopathy. Proc Natl Acad Sci U S A. 2016;113:12592-12597 pubmed
  57. Greene L, Nathwani S, Zisterer D. Inhibition of ?-secretase activity synergistically enhances tumour necrosis factor-related apoptosis-inducing ligand induced apoptosis in T-cell acute lymphoblastic leukemia cells via upregulation of death receptor 5. Oncol Lett. 2016;12:2900-2905 pubmed
  58. Stoyanova T, Riedinger M, Lin S, Faltermeier C, Smith B, Zhang K, et al. Activation of Notch1 synergizes with multiple pathways in promoting castration-resistant prostate cancer. Proc Natl Acad Sci U S A. 2016;113:E6457-E6466 pubmed
  59. Asnaghi L, Tripathy A, Yang Q, Kaur H, Hanaford A, Yu W, et al. Targeting Notch signaling as a novel therapy for retinoblastoma. Oncotarget. 2016;7:70028-70044 pubmed 出版商
  60. Krepler C, Xiao M, Samanta M, Vultur A, Chen H, Brafford P, et al. Targeting Notch enhances the efficacy of ERK inhibitors in BRAF-V600E melanoma. Oncotarget. 2016;7:71211-71222 pubmed 出版商
  61. Zhang S, Wang P, Ren L, Hu C, Bi J. Protective effect of melatonin on soluble A?1-42-induced memory impairment, astrogliosis, and synaptic dysfunction via the Musashi1/Notch1/Hes1 signaling pathway in the rat hippocampus. Alzheimers Res Ther. 2016;8:40 pubmed 出版商
  62. Guo Q, Xu H, Yang X, Zhao D, Liu S, Sun X, et al. Notch activation of Ca2+-sensing receptor mediates hypoxia-induced pulmonary hypertension. Hypertens Res. 2017;40:117-129 pubmed 出版商
  63. Zhong W, Yi Q, Xu B, Li S, Wang T, Liu F, et al. ORP4L is essential for T-cell acute lymphoblastic leukemia cell survival. Nat Commun. 2016;7:12702 pubmed 出版商
  64. Bi P, Yue F, Karki A, Castro B, Wirbisky S, Wang C, et al. Notch activation drives adipocyte dedifferentiation and tumorigenic transformation in mice. J Exp Med. 2016;213:2019-37 pubmed 出版商
  65. Hong X, Liu W, Song R, Shah J, Feng X, Tsang C, et al. SOX9 is targeted for proteasomal degradation by the E3 ligase FBW7 in response to DNA damage. Nucleic Acids Res. 2016;44:8855-8869 pubmed
  66. Jordan N, Bardia A, Wittner B, Benes C, Ligorio M, Zheng Y, et al. HER2 expression identifies dynamic functional states within circulating breast cancer cells. Nature. 2016;537:102-106 pubmed 出版商
  67. Hoare M, Ito Y, Kang T, Weekes M, Matheson N, Patten D, et al. NOTCH1 mediates a switch between two distinct secretomes during senescence. Nat Cell Biol. 2016;18:979-92 pubmed 出版商
  68. Zhang P, He D, Chen Z, Pan Q, Du F, Zang X, et al. Chemotherapy enhances tumor vascularization via Notch signaling-mediated formation of tumor-derived endothelium in breast cancer. Biochem Pharmacol. 2016;118:18-30 pubmed 出版商
  69. Ramo K, Sugamura K, Craige S, Keaney J, Davis R. Suppression of ischemia in arterial occlusive disease by JNK-promoted native collateral artery development. elife. 2016;5: pubmed 出版商
  70. Deskin B, Lasky J, Zhuang Y, Shan B. Requirement of HDAC6 for activation of Notch1 by TGF-?1. Sci Rep. 2016;6:31086 pubmed 出版商
  71. Johansson E, Rönö B, Johansson M, Lindgren D, Möller C, Axelson H, et al. Simultaneous targeted activation of Notch1 and Vhl-disruption in the kidney proximal epithelial tubular cells in mice. Sci Rep. 2016;6:30739 pubmed 出版商
  72. Fan C, Jia L, Zheng Y, Jin C, Liu Y, Liu H, et al. MiR-34a Promotes Osteogenic Differentiation of Human Adipose-Derived Stem Cells via the RBP2/NOTCH1/CYCLIN D1 Coregulatory Network. Stem Cell Reports. 2016;7:236-48 pubmed 出版商
  73. Fujiwara T, Zhou J, Ye S, Zhao H. RNA-binding protein Musashi2 induced by RANKL is critical for osteoclast survival. Cell Death Dis. 2016;7:e2300 pubmed 出版商
  74. Phillips E, Lang V, Bohlen J, Bethke F, Puccio L, Tichy D, et al. Targeting atypical protein kinase C iota reduces viability in glioblastoma stem-like cells via a notch signaling mechanism. Int J Cancer. 2016;139:1776-87 pubmed 出版商
  75. Zeng J, Jing Y, Shi R, Pan X, Lai F, Liu W, et al. Autophagy regulates biliary differentiation of hepatic progenitor cells through Notch1 signaling pathway. Cell Cycle. 2016;15:1602-10 pubmed 出版商
  76. Mathan J, Ismail S, McGhee J, McGhee C, Sherwin T. Sphere-forming cells from peripheral cornea demonstrate the ability to repopulate the ocular surface. Stem Cell Res Ther. 2016;7:81 pubmed 出版商
  77. Brosh R, Hrynyk I, Shen J, Waghray A, Zheng N, Lemischka I. A dual molecular analogue tuner for dissecting protein function in mammalian cells. Nat Commun. 2016;7:11742 pubmed 出版商
  78. Carofino B, Ayanga B, Tracey L, Brooke Bisschop T, Justice M. PRDM14 promotes RAG-dependent Notch1 driver mutations in mouse T-ALL. Biol Open. 2016;5:645-53 pubmed 出版商
  79. Li Z, Hodgkinson T, Gothard E, Boroumand S, Lamb R, Cummins I, et al. Epidermal Notch1 recruits RORγ(+) group 3 innate lymphoid cells to orchestrate normal skin repair. Nat Commun. 2016;7:11394 pubmed 出版商
  80. Huang G, Yang X, Chen K, Xing J, Guo L, Zhu L, et al. Porf-2 Inhibits Neural Stem Cell Proliferation Through Wnt/?-Catenin Pathway by Its GAP Domain. Front Cell Neurosci. 2016;10:85 pubmed 出版商
  81. Del Debbio C, Mir Q, Parameswaran S, Mathews S, Xia X, Zheng L, et al. Notch Signaling Activates Stem Cell Properties of Müller Glia through Transcriptional Regulation and Skp2-mediated Degradation of p27Kip1. PLoS ONE. 2016;11:e0152025 pubmed 出版商
  82. Lynch J, McEwen R, Crafter C, McDermott U, Garnett M, Barry S, et al. Identification of differential PI3K pathway target dependencies in T-cell acute lymphoblastic leukemia through a large cancer cell panel screen. Oncotarget. 2016;7:22128-39 pubmed 出版商
  83. Ye L, Qiu L, Zhang H, Chen H, Jiang C, Hong H, et al. Cardiomyocytes in Young Infants With Congenital Heart Disease: a Three-Month Window of Proliferation. Sci Rep. 2016;6:23188 pubmed 出版商
  84. Lakschevitz F, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200-9 pubmed 出版商
  85. Wang W, Jossin Y, Chai G, Lien W, Tissir F, Goffinet A. Feedback regulation of apical progenitor fate by immature neurons through Wnt7-Celsr3-Fzd3 signalling. Nat Commun. 2016;7:10936 pubmed 出版商
  86. Singh N, Kotla S, Kumar R, Rao G. Cyclic AMP Response Element Binding Protein Mediates Pathological Retinal Neovascularization via Modulating DLL4-NOTCH1 Signaling. EBioMedicine. 2015;2:1767-84 pubmed 出版商
  87. Liu B, Ma A, Zhang F, Wang Y, Li Z, Li Q, et al. MAZ mediates the cross-talk between CT-1 and NOTCH1 signaling during gliogenesis. Sci Rep. 2016;6:21534 pubmed 出版商
  88. Wu X, Fleming A, Ricketts T, Pavel M, Virgin H, Menzies F, et al. Autophagy regulates Notch degradation and modulates stem cell development and neurogenesis. Nat Commun. 2016;7:10533 pubmed 出版商
  89. Drier Y, Cotton M, Williamson K, Gillespie S, Ryan R, Kluk M, et al. An oncogenic MYB feedback loop drives alternate cell fates in adenoid cystic carcinoma. Nat Genet. 2016;48:265-72 pubmed 出版商
  90. Tominaga A, Cai T, Takagi Niidome S, Iwatsubo T, Tomita T. Conformational Changes in Transmembrane Domain 4 of Presenilin 1 Are Associated with Altered Amyloid-β 42 Production. J Neurosci. 2016;36:1362-72 pubmed 出版商
  91. Merk H, Zhang S, Lehr T, Müller C, Ulrich M, Bibb J, et al. Inhibition of endothelial Cdk5 reduces tumor growth by promoting non-productive angiogenesis. Oncotarget. 2016;7:6088-104 pubmed 出版商
  92. Noh H, Hah Y, Ha J, Kang M, Zada S, Rha S, et al. Regulation of the epithelial to mesenchymal transition and metastasis by Raf kinase inhibitory protein-dependent Notch1 activity. Oncotarget. 2016;7:4632-46 pubmed 出版商
  93. Bolduc D, Montagna D, Gu Y, Selkoe D, Wolfe M. Nicastrin functions to sterically hinder γ-secretase-substrate interactions driven by substrate transmembrane domain. Proc Natl Acad Sci U S A. 2016;113:E509-18 pubmed 出版商
  94. Mandasari M, Sawangarun W, Katsube K, Kayamori K, Yamaguchi A, Sakamoto K. A facile one-step strategy for the generation of conditional knockout mice to explore the role of Notch1 in oroesophageal tumorigenesis. Biochem Biophys Res Commun. 2016;469:761-7 pubmed 出版商
  95. Wang Y, Hou H, Li M, Yang Y, Sun L. Anticancer effect of eupatilin on glioma cells through inhibition of the Notch-1 signaling pathway. Mol Med Rep. 2016;13:1141-6 pubmed 出版商
  96. Chen X, Dong X, Gao H, Jiang Y, Jin Y, Chang Y, et al. Suppression of HSP27 increases the anti‑tumor effects of quercetin in human leukemia U937 cells. Mol Med Rep. 2016;13:689-96 pubmed 出版商
  97. Denicolaï E, Tabouret E, Colin C, Metellus P, Nanni I, Boucard C, et al. Molecular heterogeneity of glioblastomas: does location matter?. Oncotarget. 2016;7:902-13 pubmed 出版商
  98. Zhang Y, Yu J, Lee C, Xu B, Sartor M, Koenig R. Genomic binding and regulation of gene expression by the thyroid carcinoma-associated PAX8-PPARG fusion protein. Oncotarget. 2015;6:40418-32 pubmed 出版商
  99. Shao H, Kong R, Ferrari M, Radtke F, Capobianco A, Liu Z. Notch1 Pathway Activity Determines the Regulatory Role of Cancer-Associated Fibroblasts in Melanoma Growth and Invasion. PLoS ONE. 2015;10:e0142815 pubmed 出版商
  100. Zhao E, Maj T, Kryczek I, Li W, Wu K, Zhao L, et al. Cancer mediates effector T cell dysfunction by targeting microRNAs and EZH2 via glycolysis restriction. Nat Immunol. 2016;17:95-103 pubmed 出版商
  101. Zhang S, Schneider L, Vick B, Grunert M, Jeremias I, Menche D, et al. Anti-leukemic effects of the V-ATPase inhibitor Archazolid A. Oncotarget. 2015;6:43508-28 pubmed 出版商
  102. Fujino K, Motooka Y, Hassan W, Ali Abdalla M, Sato Y, Kudoh S, et al. Insulinoma-Associated Protein 1 Is a Crucial Regulator of Neuroendocrine Differentiation in Lung Cancer. Am J Pathol. 2015;185:3164-77 pubmed 出版商
  103. Herranz D, Ambesi Impiombato A, Sudderth J, Sánchez Martín M, Belver L, Tosello V, et al. Metabolic reprogramming induces resistance to anti-NOTCH1 therapies in T cell acute lymphoblastic leukemia. Nat Med. 2015;21:1182-9 pubmed 出版商
  104. Imai Y, Kobayashi Y, Inoshita T, Meng H, Arano T, Uemura K, et al. The Parkinson's Disease-Associated Protein Kinase LRRK2 Modulates Notch Signaling through the Endosomal Pathway. PLoS Genet. 2015;11:e1005503 pubmed 出版商
  105. Ray A, Vasudevan S, Sengupta S. 6-Shogaol Inhibits Breast Cancer Cells and Stem Cell-Like Spheroids by Modulation of Notch Signaling Pathway and Induction of Autophagic Cell Death. PLoS ONE. 2015;10:e0137614 pubmed 出版商
  106. Liu Z, Brunskill E, Varnum Finney B, Zhang C, Zhang A, Jay P, et al. The intracellular domains of Notch1 and Notch2 are functionally equivalent during development and carcinogenesis. Development. 2015;142:2452-63 pubmed 出版商
  107. Xie C, Wei D, Zhao L, Marchetto S, Mei L, Borg J, et al. Erbin is a novel substrate of the Sag-βTrCP E3 ligase that regulates KrasG12D-induced skin tumorigenesis. J Cell Biol. 2015;209:721-37 pubmed 出版商
  108. Jäger W, Xue H, Hayashi T, Janssen C, Awrey S, Wyatt A, et al. Patient-derived bladder cancer xenografts in the preclinical development of novel targeted therapies. Oncotarget. 2015;6:21522-32 pubmed
  109. Yang L, Zhang S, George S, Teng R, You X, Xu M, et al. Targeting Notch1 and proteasome as an effective strategy to suppress T-cell lymphoproliferative neoplasms. Oncotarget. 2015;6:14953-69 pubmed
  110. Gomi K, Arbelaez V, Crystal R, Walters M. Activation of NOTCH1 or NOTCH3 signaling skews human airway basal cell differentiation toward a secretory pathway. PLoS ONE. 2015;10:e0116507 pubmed 出版商
  111. Sato M, Rodríguez Barrueco R, Yu J, Do C, Silva J, Gautier J. MYC is a critical target of FBXW7. Oncotarget. 2015;6:3292-305 pubmed
  112. Nguyen D, Rubinstein L, Takebe N, Miele L, Tomaszewski J, Ivy P, et al. Notch1 phenotype and clinical stage progression in non-small cell lung cancer. J Hematol Oncol. 2015;8:9 pubmed 出版商
  113. Sun Z, Zhang C, Zou X, Jiang G, Xu Z, Li W, et al. Special AT-rich sequence-binding protein-1 participates in the maintenance of breast cancer stem cells through regulation of the Notch signaling pathway and expression of Snail1 and Twist1. Mol Med Rep. 2015;11:3235-542 pubmed 出版商
  114. Lim K, Brandt W, Heth J, Muraszko K, Fan X, Bar E, et al. Lateral inhibition of Notch signaling in neoplastic cells. Oncotarget. 2015;6:1666-77 pubmed
  115. Kaushik G, Venugopal A, Ramamoorthy P, Standing D, Subramaniam D, Umar S, et al. Honokiol inhibits melanoma stem cells by targeting notch signaling. Mol Carcinog. 2015;54:1710-21 pubmed 出版商
  116. Dong X, Lin Q, Aihara A, Li Y, Huang C, Chung W, et al. Aspartate β-Hydroxylase expression promotes a malignant pancreatic cellular phenotype. Oncotarget. 2015;6:1231-48 pubmed
  117. Nakamura M, Shibata K, Hatano S, Sato T, Ohkawa Y, Yamada H, et al. A genome-wide analysis identifies a notch-RBP-Jκ-IL-7Rα axis that controls IL-17-producing γδ T cell homeostasis in mice. J Immunol. 2015;194:243-51 pubmed 出版商
  118. Xie F, Cai W, Liu Y, Li Y, Du B, Feng L, et al. Vaccarin attenuates the human EA.hy926 endothelial cell oxidative stress injury through inhibition of Notch signaling. Int J Mol Med. 2015;35:135-42 pubmed 出版商
  119. Ortega M, Bhatnagar H, Lin A, Wang L, Aster J, Sill H, et al. A microRNA-mediated regulatory loop modulates NOTCH and MYC oncogenic signals in B- and T-cell malignancies. Leukemia. 2015;29:968-76 pubmed 出版商
  120. Kakar S, Ratajczak M, Powell K, Moghadamfalahi M, Miller D, Batra S, et al. Withaferin a alone and in combination with cisplatin suppresses growth and metastasis of ovarian cancer by targeting putative cancer stem cells. PLoS ONE. 2014;9:e107596 pubmed 出版商
  121. Singla R, Wang J, Singla D. Regulation of Notch 1 signaling in THP-1 cells enhances M2 macrophage differentiation. Am J Physiol Heart Circ Physiol. 2014;307:H1634-42 pubmed 出版商
  122. So J, Lin J, Wahler J, Liby K, Sporn M, Suh N. A synthetic triterpenoid CDDO-Im inhibits tumorsphere formation by regulating stem cell signaling pathways in triple-negative breast cancer. PLoS ONE. 2014;9:e107616 pubmed 出版商
  123. Arasada R, Amann J, Rahman M, Huppert S, Carbone D. EGFR blockade enriches for lung cancer stem-like cells through Notch3-dependent signaling. Cancer Res. 2014;74:5572-84 pubmed 出版商
  124. Wang H, Huang X, Zhang J, Shao N, Chen L, Ma D, et al. The expression of VEGF and Dll4/Notch pathway molecules in ovarian cancer. Clin Chim Acta. 2014;436:243-8 pubmed 出版商
  125. Aydin I, Melamed R, Adams S, Castillo Martin M, Demir A, Bryk D, et al. FBXW7 mutations in melanoma and a new therapeutic paradigm. J Natl Cancer Inst. 2014;106:dju107 pubmed 出版商
  126. Kumar V, Palermo R, Talora C, Campese A, Checquolo S, Bellavia D, et al. Notch and NF-kB signaling pathways regulate miR-223/FBXW7 axis in T-cell acute lymphoblastic leukemia. Leukemia. 2014;28:2324-35 pubmed 出版商
  127. Redmond E, Liu W, Hamm K, Hatch E, Cahill P, Morrow D. Perivascular delivery of Notch 1 siRNA inhibits injury-induced arterial remodeling. PLoS ONE. 2014;9:e84122 pubmed 出版商
  128. Xiong H, Maraver A, Latkowski J, Henderson T, Schlessinger K, Ding Y, et al. Characterization of two distinct lymphoproliferative diseases caused by ectopic expression of the Notch ligand DLL4 on T cells. PLoS ONE. 2013;8:e84841 pubmed 出版商
  129. Gupta R, Sharma M, Suri V, Kakkar A, Singh M, Sarkar C. Study of chromosome 9q gain, Notch pathway regulators and Tenascin-C in ependymomas. J Neurooncol. 2014;116:267-74 pubmed 出版商
  130. Battle M, Gillespie C, Quarshie A, Lanier V, Harmon T, Wilson K, et al. Obesity induced a leptin-Notch signaling axis in breast cancer. Int J Cancer. 2014;134:1605-16 pubmed 出版商
  131. Murta D, Batista M, Silva E, Trindade A, Henrique D, Duarte A, et al. Dynamics of Notch pathway expression during mouse testis post-natal development and along the spermatogenic cycle. PLoS ONE. 2013;8:e72767 pubmed 出版商
  132. Sha L, Wu X, Yao Y, Wen B, Feng J, Sha Z, et al. Notch signaling activation promotes seizure activity in temporal lobe epilepsy. Mol Neurobiol. 2014;49:633-44 pubmed 出版商
  133. Yoshida R, Nagata M, Nakayama H, Niimori Kita K, Hassan W, Tanaka T, et al. The pathological significance of Notch1 in oral squamous cell carcinoma. Lab Invest. 2013;93:1068-81 pubmed 出版商
  134. El Hindy N, Keyvani K, Pagenstecher A, Dammann P, Sandalcioglu I, Sure U, et al. Implications of Dll4-Notch signaling activation in primary glioblastoma multiforme. Neuro Oncol. 2013;15:1366-78 pubmed 出版商
  135. Qin L, Xu J, Wu Z, Zhang Z, Li J, Wang C, et al. Notch1-mediated signaling regulates proliferation of porcine satellite cells (PSCs). Cell Signal. 2013;25:561-9 pubmed 出版商
  136. Sundlisaeter E, Edelmann R, Hol J, Sponheim J, Küchler A, WEISS M, et al. The alarmin IL-33 is a notch target in quiescent endothelial cells. Am J Pathol. 2012;181:1099-111 pubmed 出版商
  137. Sakamoto K, Chao W, Katsube K, Yamaguchi A. Distinct roles of EGF repeats for the Notch signaling system. Exp Cell Res. 2005;302:281-91 pubmed